NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes

Abstract Background Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great promise for regenerative medicine and in drugs screening. Despite displaying key cardiomyocyte phenotypic characteristics, they more closely resemble fetal/neonatal cardiomyocytes and are still imma...

Full description

Bibliographic Details
Main Authors: Xinyuan Zhang, Liang Ye, Hao Xu, Qin Zhou, Bin Tan, Qin Yi, Liang Yan, Min Xie, Yin Zhang, Jie Tian, Jing Zhu
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13287-021-02264-2
id doaj-eba6cf288f574778b4d2afc7481472c6
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Xinyuan Zhang
Liang Ye
Hao Xu
Qin Zhou
Bin Tan
Qin Yi
Liang Yan
Min Xie
Yin Zhang
Jie Tian
Jing Zhu
spellingShingle Xinyuan Zhang
Liang Ye
Hao Xu
Qin Zhou
Bin Tan
Qin Yi
Liang Yan
Min Xie
Yin Zhang
Jie Tian
Jing Zhu
NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes
Stem Cell Research & Therapy
Nuclear factor erythroid 2 p45-related factor 2 (NRF2)
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)
Metabolism
author_facet Xinyuan Zhang
Liang Ye
Hao Xu
Qin Zhou
Bin Tan
Qin Yi
Liang Yan
Min Xie
Yin Zhang
Jie Tian
Jing Zhu
author_sort Xinyuan Zhang
title NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes
title_short NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes
title_full NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes
title_fullStr NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes
title_full_unstemmed NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes
title_sort nrf2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes
publisher BMC
series Stem Cell Research & Therapy
issn 1757-6512
publishDate 2021-03-01
description Abstract Background Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great promise for regenerative medicine and in drugs screening. Despite displaying key cardiomyocyte phenotypic characteristics, they more closely resemble fetal/neonatal cardiomyocytes and are still immature; these cells mainly rely on glucose as a substrate for metabolic energy, while mature cardiomyocytes mainly employ oxidative phosphorylation of fatty acids. Studies showed that the alteration of metabolism pattern from glycolysis to oxidative phosphorylation improve the maturity of hiPSC-CMs. As a transcription factor, accumulating evidences showed the important role of NRF2 in the regulation of energy metabolism, which directly regulates the expression of mitochondrial respiratory complexes. Therefore, we hypothesized that NRF2 is involved in the maturation of hiPSC-CMs. Methods The morphological and functional changes related to mitochondria and cell maturation were analyzed by knock-down and activation of NRF2. Results The results showed that the inhibition of NRF2 led to the retardation of cell maturation. The activation of NRF2 leads to a more mature hiPSC-CMs phenotype, as indicated by the increase of cardiac maturation markers, sarcomere length, calcium transient dynamics, the number and fusion events of mitochondria, and mitochondrial respiration. Bioinformatics analysis showed that in addition to metabolism-related genes, NRF2 also activates the expression of myocardial ion channels. Conclusions These findings indicated that NRF2 plays an important role in the maturation of hiPSC-CMs. The present work provides greater insights into the molecular regulation of hiPSC-CMs metabolism and theoretical basis in drug screening, disease modeling, and alternative treatment.
topic Nuclear factor erythroid 2 p45-related factor 2 (NRF2)
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)
Metabolism
url https://doi.org/10.1186/s13287-021-02264-2
work_keys_str_mv AT xinyuanzhang nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes
AT liangye nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes
AT haoxu nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes
AT qinzhou nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes
AT bintan nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes
AT qinyi nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes
AT liangyan nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes
AT minxie nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes
AT yinzhang nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes
AT jietian nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes
AT jingzhu nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes
_version_ 1724200433571856384
spelling doaj-eba6cf288f574778b4d2afc7481472c62021-03-28T11:09:23ZengBMCStem Cell Research & Therapy1757-65122021-03-0112111510.1186/s13287-021-02264-2NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytesXinyuan Zhang0Liang Ye1Hao Xu2Qin Zhou3Bin Tan4Qin Yi5Liang Yan6Min Xie7Yin Zhang8Jie Tian9Jing Zhu10Department of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children’s Hospital of Chongqing Medical UniversityDepartment of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children’s Hospital of Chongqing Medical UniversityChongqing Key Laboratory of PediatricsDepartment of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children’s Hospital of Chongqing Medical UniversityDepartment of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children’s Hospital of Chongqing Medical UniversityDepartment of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children’s Hospital of Chongqing Medical UniversityDepartment of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children’s Hospital of Chongqing Medical UniversityDepartment of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children’s Hospital of Chongqing Medical UniversityDepartment of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children’s Hospital of Chongqing Medical UniversityChongqing Key Laboratory of PediatricsDepartment of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children’s Hospital of Chongqing Medical UniversityAbstract Background Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great promise for regenerative medicine and in drugs screening. Despite displaying key cardiomyocyte phenotypic characteristics, they more closely resemble fetal/neonatal cardiomyocytes and are still immature; these cells mainly rely on glucose as a substrate for metabolic energy, while mature cardiomyocytes mainly employ oxidative phosphorylation of fatty acids. Studies showed that the alteration of metabolism pattern from glycolysis to oxidative phosphorylation improve the maturity of hiPSC-CMs. As a transcription factor, accumulating evidences showed the important role of NRF2 in the regulation of energy metabolism, which directly regulates the expression of mitochondrial respiratory complexes. Therefore, we hypothesized that NRF2 is involved in the maturation of hiPSC-CMs. Methods The morphological and functional changes related to mitochondria and cell maturation were analyzed by knock-down and activation of NRF2. Results The results showed that the inhibition of NRF2 led to the retardation of cell maturation. The activation of NRF2 leads to a more mature hiPSC-CMs phenotype, as indicated by the increase of cardiac maturation markers, sarcomere length, calcium transient dynamics, the number and fusion events of mitochondria, and mitochondrial respiration. Bioinformatics analysis showed that in addition to metabolism-related genes, NRF2 also activates the expression of myocardial ion channels. Conclusions These findings indicated that NRF2 plays an important role in the maturation of hiPSC-CMs. The present work provides greater insights into the molecular regulation of hiPSC-CMs metabolism and theoretical basis in drug screening, disease modeling, and alternative treatment.https://doi.org/10.1186/s13287-021-02264-2Nuclear factor erythroid 2 p45-related factor 2 (NRF2)Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)Metabolism